DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 065329
The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There are twenty-four drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 065329
Tradename: | CEFTRIAXONE |
Applicant: | Acs Dobfar |
Ingredient: | ceftriaxone sodium |
Patents: | 0 |
Therapeutic Class: | Antibacterials |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 065329
Ingredient-type | Cephalosporins |
Medical Subject Heading (MeSH) Categories for 065329
Suppliers and Packaging for NDA: 065329
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065329 | ANDA | Sagent Pharmaceuticals | 25021-105 | N | 25021-105-66 |
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065329 | ANDA | Sagent Pharmaceuticals | 25021-105 | N | 25021-105-10 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Complete Access Available with Subscription